BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33275458)

  • 21. Impact of
    Al-Ibraheem A; Hirmas N; Fanti S; Paez D; Abuhijla F; Al-Rimawi D; Al-Rasheed U; Abdeljalil R; Hawari F; Alrabi K; Mansour A
    BMC Med Imaging; 2021 Mar; 21(1):49. PubMed ID: 33731050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between endobronchial ultrasound-guided (EBUS)-transbronchial needle aspiration utility and computed tomography staging, node size at EBUS, and positron emission tomography scan node standard uptake values: A retrospective analysis.
    Marchand C; Medford ARL
    Thorac Cancer; 2017 Jul; 8(4):285-290. PubMed ID: 28436173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suitability of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration versus Paired Transbronchial Biopsy Specimens for Evaluating Programmed Death Ligand-1 Expression in Stage III and IV Lung Cancer: A Comparative Retrospective Study.
    Matsuoka H; Araya T; Kita T; Terada N; Yamamura K; Nishikawa S; Tambo Y; Sone T; Kimura H; Ooi A; Kasashima S; Kawashima A; Kasahara K
    J Cancer; 2021; 12(15):4478-4487. PubMed ID: 34149911
    [No Abstract]   [Full Text] [Related]  

  • 24. Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.
    Karadzovska-Kotevska M; Brunnström H; Kosieradzki J; Ek L; Estberg C; Staaf J; Barath S; Planck M
    PLoS One; 2022; 17(2):e0263342. PubMed ID: 35108331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Hara N; Ichihara E; Harada D; Inoue K; Fujiwara K; Hosokawa S; Kishino D; Haruyuki K; Ochi N; Oda N; Hotta K; Maeda Y; Kiura K
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3749-3755. PubMed ID: 33779840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of an Additional 19-G EBUS-TBNA Needle Increases the Diagnostic Yield of EBUS-TBNA.
    Garrison G; Leclair T; Balla A; Wagner S; Butnor K; Anderson SR; Kinsey CM
    J Bronchology Interv Pulmonol; 2018 Oct; 25(4):269-273. PubMed ID: 29901535
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Hu B; Chen W; Zhang Y; Shi H; Cheng D; Xiu Y
    Ann Nucl Med; 2020 May; 34(5):322-328. PubMed ID: 32130663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer.
    Miyazawa T; Otsubo K; Sakai H; Kimura H; Chosokabe M; Morikawa K; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
    Cancer Control; 2021; 28():10732748211038314. PubMed ID: 34384268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
    Noll B; Wang WL; Gong Y; Zhao J; Kalhor N; Prieto V; Staerkel G; Roy-Chowdhuri S
    Cancer Cytopathol; 2018 May; 126(5):342-352. PubMed ID: 29499101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of convex probe endobronchial ultrasound (CP-EBUS) assisted transbronchial needle aspiration for mediastinal staging in non-small cell lung cancer cases with mediastinal lymphadenopathy.
    Cetinkaya E; Seyhan EC; Ozgul A; Gencoglu A; Ozgul G; Cam E; Kamiloglu E
    Ann Thorac Cardiovasc Surg; 2011; 17(3):236-42. PubMed ID: 21697783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endobronchial ultrasound in diagnosing and staging of lung cancer by Acquire 22G TBNB versus regular 22G TBNA needles: study protocol of a randomised clinical trial.
    Kuijvenhoven JC; Kramer T; Korevaar DA; Ninaber MK; Trisolini R; Szlubowski A; Gnass M; von der Thüsen J; Cohen D; Bonta PI; Annema JT
    BMJ Open; 2021 Sep; 11(9):e051820. PubMed ID: 34475187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of PD-L1 Expression with
    Huisman MC; Niemeijer AN; Windhorst AD; Schuit RC; Leung D; Hayes W; Poot A; Bahce I; Radonic T; Oprea-Lager DE; Hoekstra OS; Thunnissen E; Hendrikse NH; Smit EF; de Langen AJ; Boellaard R
    J Nucl Med; 2020 Oct; 61(10):1455-1460. PubMed ID: 32060213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic ultrasound-guided fine needle aspiration and endobronchial ultrasound-guided transbronchial needle aspiration: Are two better than one in mediastinal staging of non-small cell lung cancer?
    Oki M; Saka H; Ando M; Kitagawa C; Kogure Y; Seki Y
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1169-77. PubMed ID: 24930616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on
    Takada K; Toyokawa G; Okamoto T; Baba S; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Honda H; Oda Y; Maehara Y
    Cancer Med; 2017 Nov; 6(11):2552-2561. PubMed ID: 28980429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Prospective, Randomized Trial for the Comparison of 19-G and 22-G Endobronchial Ultrasound-Guided Transbronchial Aspiration Needles; Introducing a Novel End Point of Sample Weight Corrected for Blood Content.
    Wolters C; Darwiche K; Franzen D; Hager T; Bode-Lesnievska B; Kneuertz PJ; He K; Koenig M; Freitag L; Wei L; Eisenmann S; Taube C; Weinreich G; Oezkan F
    Clin Lung Cancer; 2019 May; 20(3):e265-e273. PubMed ID: 30914312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic performance of endobronchial ultrasound-guided mediastinal lymph node sampling in early stage non-small cell lung cancer: A prospective study.
    Vial MR; O'Connell OJ; Grosu HB; Hernandez M; Noor L; Casal RF; Stewart J; Sarkiss M; Jimenez CA; Rice D; Mehran R; Ost DE; Eapen GA
    Respirology; 2018 Jan; 23(1):76-81. PubMed ID: 28857362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens.
    Heymann JJ; Bulman WA; Swinarski D; Pagan CA; Crapanzano JP; Haghighi M; Fazlollahi L; Stoopler MB; Sonett JR; Sacher AG; Shu CA; Rizvi NA; Saqi A
    Cancer Cytopathol; 2017 Dec; 125(12):896-907. PubMed ID: 29024471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of programmed death ligand 1 expression in paired cytologic and histologic specimens of non-small cell lung cancer.
    Daverio M; Patrucco F; Gavelli F; Airoldi C; Sciortino G; Chiaramonte C; Rena O; Balbo PE; Boldorini RL
    Cancer Cytopathol; 2020 Aug; 128(8):580-588. PubMed ID: 32463583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the Clinical Performance of the New 19-G ViziShot FLEX and 21- or 22-G ViziShot 2 Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Needles.
    Minami D; Ozeki T; Okawa S; Takada K; Iwamoto Y; Kayatani H; Sato K; Fujiwara K; Shibayama T
    Intern Med; 2018 Dec; 57(24):3515-3520. PubMed ID: 30146572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-L1 Expression in a Non-Small Cell Lung Cancer Specimen Obtained by EBUS-TBNA.
    Fernandez-Bussy S; Pires Y; Labarca G; Vial MR
    Arch Bronconeumol (Engl Ed); 2018 May; 54(5):290-292. PubMed ID: 29223638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.